Nafamostat mesilate, as a treatment for heparin resistance, is not associated with perioperative ischemic stroke in patients undergoing cardiac surgery with cardiopulmonary bypass

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 26, Issue 2, 2012, Pages 239-244

  Kikura, Mutsuhito ^a,b   Tanaka, Keizo ^b   Hiraiwa, Takane ^b   Tanaka, Kuniyoshi ^b  

^a HAMAMATSU ROSAI HOSPITAL   (Japan)

^b HAMAMATSU MEDICAL CENTER   (Japan)

Author keywords

cardiac surgery; cardiopulmonary bypass; heparin resistance; ischemic stroke; nafamostat mesilate

Indexed keywords

HEPARIN; NAFAMSTAT MESILATE; TRANEXAMIC ACID;

ADULT; AGED; ARTICLE; BLOOD CLOTTING TIME; BRAIN ISCHEMIA; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS GRAFT; DRUG RESISTANCE; FEMALE; HEART SURGERY; HEPARIN RESISTANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGED; BRAIN ISCHEMIA; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; COHORT STUDIES; DRUG RESISTANCE; FEMALE; GUANIDINES; HEPARIN; HUMANS; MALE; MIDDLE AGED; PERIOPERATIVE CARE; PROTEASE INHIBITORS; RETROSPECTIVE STUDIES; STROKE; TREATMENT OUTCOME;

EID: 84858159081     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2011.09.002     Document Type: Article

References (24)

1. C.W. Choi, D.H. Kang, G.H. Kim Nafamostat mesilate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis Gastrointest Endosc 69 2009 e11 e18
2. K. Yamamoto, H. Ito, T. Hiraiwa Effects of nafamostat mesilate on coagulopathy with chronic aortic dissection Ann Thorac Surg 88 2009 1331 1333
3. T. Shinoda Anticoagulation in acute blood purification for acute renal failure in critical care Contrib Nephrol 166 2010 119 125
4. T. Sato, K. Tanaka, C. Kondo Nafamostat mesilate administration during cardiopulmonary bypass decreases postoperative bleeding after cardiac surgery ASAIO Trans 37 1991 M194 M195
5. M. Murase, A. Usui, Y. Tomita Nafamostat mesilate reduces blood loss during open heart surgery Circulation 88 1993 II432 II436
6. K. Tanaka, C. Kondo, K. Takagi Effects of nafamostat mesilate on platelets and coagulofibrinolysis during cardiopulmonary bypass surgery ASAIO J 39 1993 M545 M549
7. A. Usui, M. Hiroura, M. Kawamura Nafamostat mesilate reduces blood-foreign surface reactions similar to biocompatible materials Ann Thorac Surg 62 1996 1404 1411 (Pubitemid 26383541)
8. K. Nakamura, T. Onitsuka, M. Yano Influence of heparin dosage on hemostasis under combined use of nafamostat mesilate during deep hypothermic circulatory arrest Jpn J Thorac Cardiovasc Surg 51 2003 186 191 (Pubitemid 38166287)
9. B.D. Spiess Treating heparin resistance with antithrombin or fresh frozen plasma Ann Thorac Surg 85 2008 2153 2160 (Pubitemid 351685591)
10. K. Tanaka, M. Takao, I. Yada Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery J Cardiothorac Anesth 3 1989 181 188 (Pubitemid 19098790)
11. L.H. Edmunds Jr, R.W. Colman Thrombin during cardiopulmonary bypass Ann Thorac Surg 82 2006 2315 2322 (Pubitemid 44794379)
12. M. Selim Perioperative stroke N Engl J Med 356 2007 706 713
13. M. Kikura, B.T. Bateman, K.A. Tanaka Perioperative ischemic stroke in non-cardiovascular surgery patients J Anesth 24 2010 733 738
14. J. Bucerius, J.F. Gummert, M.A. Borger Stroke after cardiac surgery: A risk factor analysis of 16,184 consecutive adult patients Ann Thorac Surg 75 2003 472 478 (Pubitemid 36184491)
15. E. Ovrum, G. Tangen, R. Oystese Heparin-coated circuits (Duraflo II) with reduced versus full anticoagulation during coronary artery bypass surgery J Cardiovasc Surg 18 2003 140 146 (Pubitemid 36470288)
16. M. Ranucci, G. Isgr, A. Cazzaniga Different patterns of heparin resistance: Therapeutic implications Perfusion 17 2002 199 204 (Pubitemid 34467126)
17. S. Fujii, Y. Hitomi New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin Biochim Biophys Acta 661 1981 342 345 (Pubitemid 12233442)
18. T. Aoyama, Y. Ino, M. Ozeki Pharmacological studies of FUT-175, nafamstat mesilate I. Inhibition of protease activity in in vitro and in vivo experiments Jpn J Pharmacol 35 1984 203 227 (Pubitemid 14124814)
19. I. Fuse, W. Higuchi, K. Toba Inhibitory mechanism of human platelet aggregation by nafamostat mesilate Platelets 10 1999 212 218 (Pubitemid 29391083)
20. S. Sundaram, N. Gikakis, C.E. Hack Nafamostat mesilate, a broad spectrum protease inhibitor, modulates platelet, neutrophil and contact activation in simulated extracorporeal circulation Thromb Haemost 75 1996 76 82 (Pubitemid 26051198)
21. Y. Hitomi, N. Ikari, S. Fujii Inhibitory effect of a new synthetic protease inhibitor (FUT-175) on the coagulation system Haemostasis 15 1985 164 168 (Pubitemid 15037264)
22. Y. Kaminishi, Y. Hiramatsu, Y. Watanabe Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass Ann Thorac Surg 77 2004 644 650 (Pubitemid 38186526)
23. D.T. Mangano, I.C. Tudor, C. Dietzel The risk associated with aprotinin in cardiac surgery N Engl J Med 354 2006 353 365 (Pubitemid 43145060)
24. D.T. Mangano Perioperative cardiac morbidity Anesthesiology 72 1990 153 184 (Pubitemid 20031326)